NCT03459222 2026-04-06
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
Phase 1/2 Completed
Clinical Trials
125 trialsNCT05605509 2026-02-06
RP-6306 in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT03994601 2026-01-20
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
Bristol-Myers Squibb
Phase 1/2 Completed
NCT04590885 2026-01-20
CCST2
Duke University
Phase NA Completed
NCT02743494 2025-11-18
CheckMate 577
Bristol-Myers Squibb
Phase 3 Completed
NCT03369223 2025-11-18
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT05025085 2025-10-15
A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors
Agenus Inc.
Phase 1 Completed
NCT03900442 2025-09-02
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
Prescient Therapeutics, Ltd.
Phase 1 Completed
NCT04467593 2025-08-05
MATTERS
ElmediX
Phase NA Completed
NCT04936568 2025-07-08
PCRSS
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed
NCT05113199 2025-03-03
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
Mayo Clinic
Phase NA Completed
NCT03261011 2025-02-28
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors
Akeso
Phase 1 Completed
NCT03352531 2025-02-28
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
Akeso
Phase 1 Completed
NCT05315427 2025-02-14
MSPD
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT04149704 2025-01-20
Videos for Advance Care Planning in Young Adults
Dana-Farber Cancer Institute
Phase NA Completed
NCT03325985 2025-01-13
EMPallA
NYU Langone Health
Phase NA Completed
NCT03408314 2024-11-29
The PediQUEST Response Intervention Study
Massachusetts General Hospital
Phase NA Completed
NCT02193633 2024-09-26
TAX-TORC
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT02338622 2024-09-26
ComPAKT
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT05298592 2024-09-26
A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
Bristol-Myers Squibb
Phase 1 Completed
NCT01394016 2024-09-19
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT03763032 2024-09-19
Psychosocial Intervention in Latino Patients with Advanced Cancer
University of Colorado, Denver
Phase NA Completed
NCT04335253 2024-09-19
First-In-Human Study of EOS884448 in Participants with Advanced Cancers.
iTeos Therapeutics
Phase 1 Completed
NCT01954316 2024-01-17
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
University Health Network, Toronto
Phase 1 Completed
NCT04480008 2024-01-16
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers
Mayo Clinic
Phase NA Completed
NCT00610194 2023-10-18
Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
Bayer
Phase 1 Completed
NCT00625638 2023-09-21
Interactive Voice Response System in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase NA Completed
NCT02430467 2023-08-25
Caregiver-Guided Pain Management Training in Palliative Care
Duke University
Phase NA Completed
NCT05910541 2023-06-18
The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers
University Malaysia Sarawak
Phase NA Completed
NCT04254926 2023-06-08
Revie⊕
School of Health Sciences Geneva
Phase NA Completed
NCT04772690 2023-03-07
BAL
REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care
Phase NA Completed
NCT00658671 2023-02-06
A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
CASI Pharmaceuticals, Inc.
Phase 1 Completed
NCT02996110 2022-12-19
FRACTION-RCC
Bristol-Myers Squibb
Phase 2 Completed
NCT03335540 2022-09-26
ADVISE
Bristol-Myers Squibb
Phase 1 Completed
NCT01113476 2022-09-02
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03040102 2022-08-30
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Massachusetts General Hospital
Phase NA Completed
NCT00559182 2022-07-26
A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT03610243 2022-06-03
Patient-centered Self-administered Acupressure for Fatigue Management in Chinese Advanced Cancer Patients
The University of Hong Kong
Phase NA Completed
NCT03312842 2022-05-26
A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1 Completed
NCT03851146 2022-05-03
LeY-CAR-T
Peter MacCallum Cancer Centre, Australia
Phase 1 Completed
NCT03579628 2022-03-24
DRIIV-1
Valerio Therapeutics
Phase 1 Completed
NCT03203876 2022-03-10
A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed
NCT03792750 2022-02-28
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT03475251 2022-02-18
A Study of CS1003 in Subjects With Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1 Completed
NCT02737475 2022-01-25
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
Phase 1/2 Completed
NCT01143779 2022-01-04
FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00687505 2021-12-13
Safety Study of FP-1039 To Treat Cancer
Five Prime Therapeutics, Inc.
Phase 1 Completed
NCT04640714 2021-11-19
Care Transition Intervention for Patients With Cancer
Massachusetts General Hospital
Phase NA Completed
NCT02407990 2021-11-17
Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors
BeiGene
Phase 1 Completed
NCT03661632 2021-11-08
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed